The COVID-19 Back-to-normal study was initiated in January 2021 as an effort of a tight-knit neighborhood to help each other avoid the virus and vaccinate safely.
Later the research protocol was approved by MEBO Research IRB and the study was open to other communities around the world.
By now, we have over 600 participants.
Early results of the study in MEBO/PATM community, based on the replies of the first 26 enrollees, showed that while reactions to vaccine were similar to the general population, experiences with COVID-19 infections were not - 2 individuals were not able to avoid the disease in this group, and both of them experienced long term effects.
As of today, we have stories from 41 members of MEBO/PATM community and 6 different vaccines: AstraZeneca-Oxford, Johnson & Johnson’s single-shot, Moderna, Pfizer-BioNTech, Sinovac Biotech’s CoronaVac and BBIBP-CorV, also known as the Sinopharm vaccine.
Why is MEBO/PATM community more susceptible to long COVID? A new study argues that long-haulers might actually be experiencing an attack of fatigue-inducing Epstein-Barr virus (EBV, a member of herpesvirus family HHV-4) that was lying dormant in their bodies. For this study, Gold and his colleagues analyzed blood of 30 people with chronic COVID (out of 185 COVID survivors). 20 out of these 30 carried high levels of EBV antibodies. Vaccines were shown to reactivate viruses too, in much rarer cases. As was demonstrated for Pfizer vaccine that woke up another herpes virus, chickenpox herpes-zoster (HHV-3), that causes shingles when reactivated (this happened to 1% of patients with autoimmune inflammatory rheumatic diseases). Herpes simplex (HSV-1) can be also kept in remission by a healthy immune system and can be also reactivated by COVID-19.
MEBO and PATM symptoms could arise following an infection. Perhaps SARS-CoV-2 can reactivate the old viruses that caused these symptoms to begin with?
Community immunity (also known as herd immunity) protects everyone. We hope that MEBO/PATM community stays COVID-free and safe.
April 7, 2021: Vaccine to cure body odor? There could be a vaccine for everything. But there are still a lot of unknowns when it comes to individual differences in reactions to existing vaccines.
March 20, 2021: Anaphylaxis to COVID-19 vaccines : What do we know about anaphylactic reactions to Astrazeneca, Pfizer, Moderna, Johnson & Johnson & other COVID-19 vaccines?
January 20, 2021: Irritable Bowel and COVID-19 : Abdominal pain is less widely known as a symptom of COVID-19, yet it is - along with shortness of breath and confusion - a potential sign of the most severe form of COVID-19. In children, having gastrointestinal symptoms was more frequently associated with severe and critical phenotype.